Skip to Main Content

Author Details

Maya S Safarova
University of Kansas Hospital and Medical Center
2011
48
14
PMIDPaper TitleJournal TitlePublished Year
37301757Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies.J Am Heart Assoc2023
37273067Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a).Curr Atheroscler Rep2023
36344291Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors.Atherosclerosis2022
35369930Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Atrial Fibrillation.Am J Cardiol2022
35718549Effect of Lipoprotein Apheresis on Progression of Carotid Intima-Media Thickness in Patients with Severe Hypercholesterolemia.Am J Cardiol2022
36042836Severe Hypertriglyceridemia as a Cause of Aortic Thrombus with Peripheral Embolic Complications.Kans J Med2022
33407432Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohort.BMC Med Genomics2021
33854068Genetic basis of hypercholesterolemia in adults.NPJ Genom Med2021
34396023The Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Myocardial Infarction and Mortality.J Endocr Soc2021
34188061Author Correction: Genetic basis of hypercholesterolemia in adults.NPJ Genom Med2021
34168341A call for training programmes in cardiovascular genomics.Nat Rev Cardiol2021
34282949Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.Circ Genom Precis Med2021
32546049Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.Circulation2020
32073412Using the electronic health record for genomics research.Curr Opin Lipidol2020
30934954Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels.Biomolecules2019
31070467Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report.Arterioscler Thromb Vasc Biol2019
29301842Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.Circ Res2018
30225440A Clinical Decision Support Tool for Familial Hypercholesterolemia Based on Physician Input.Mayo Clin Proc Innov Qual Outcomes2018
30392543The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.Mayo Clin Proc2018
29096833Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.Atheroscler Suppl2017
28150922Child-Parent Familial Hypercholesterolemia Screening in Primary Care.N Engl J Med2017
28145427Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.Eur J Hum Genet2017
29096836Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.Atheroscler Suppl2017
26746227Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?Eur J Prev Cardiol2016
28290851[Degenerative Aortic Stenosis: Modern View on Development, Course, and Management].Kardiologiia2016
27678441Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.J Clin Lipidol2016
27261867My Approach to the Patient With Familial Hypercholesterolemia.Mayo Clin Proc2016
27438122Association of a Family History of Coronary Heart Disease With Initiation of Statin Therapy in Individuals at Intermediate Risk: Post Hoc Analysis of a Randomized Clinical Trial.JAMA Cardiol2016
25181645Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis.J Clin Apher2015
28294910[Comparison of Atherosclerotic Lesions in Patients With Acute Myocardial Infarction and Stable Angina Pectoris Using Intravascular Ultrasound].Kardiologiia2015
28294902[Evolution of Lipoprotein(a): From Biomarker to the Therapeutic Target].Kardiologiia2015
28294834[Transcatheter Treatment of Degenerative Critical Aortic Valve Stenosis in a Patient With Severe Heart Failure and Chronic Lymphocytic Leukemia].Kardiologiia2015
26502507[The Evolution of Views on Lipoprotein(a): From Biomarker to the Therapeutic Target].Kardiologiia2015
26688920[Comparison of Atherosclerotic Lesions in Patients With Acute Myocardial Infarction and Stable Angina Pectoris Using Intravascular Ultrasound].Kardiologiia2015
26050498[Transcatheter treatment of degenerative critical aortic valve stenosis in a patient with severe heart failure and chronic lymphocytic leukemia].Kardiologiia2015
26226683[Conventional and novel cardiovascular risk factors and predisposition to the development of atherosclerosis].Patol Fiziol Eksp Ter2015
25936321Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.Atheroscler Suppl2015
25936305Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.Atheroscler Suppl2015
24952151Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.Atherosclerosis2014
25499949Variance in niacin response in individuals with elevated lipoprotein(a).J Clin Lipidol2014
25177780[Effect of cascade plasma filtration on spectrum of subfractions of low density lipoproteins in blood plasma of patients with ischemic heart disease].Kardiologiia2014
23357149Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.Atheroscler Suppl2013
23357167Ig apheresis for the treatment of severe DCM patients.Atheroscler Suppl2013
23357150Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins.Atheroscler Suppl2013
21649590[Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].Kardiologiia2011
21626797[High level of lipoprotein (a) as a predictor of poor long-term prognosis after coronary artery bypass surgery].Kardiologiia2011
22117674[Value of the spectral analysis of radiofrequency intravascular ultrasound data in the evaluation of nonsignificant coronary lesions in chronic CHD patients].Kardiologiia2011
22204727Images in clinical medicine. A head shot.N Engl J Med2011
  • 1 - 48 of 48

Recommended Authors

Michael G Silverman
Massachusetts General Hospital
Career Start Year 2011
Number of shared co-authors 1
Marcus E Kleber
Heidelberg University
Career Start Year 2009
Number of shared co-authors 18
Xiaoming Jia
Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 2
Calvin Yeang
University of California
Career Start Year 2007
Number of shared co-authors 0
Ariel Brautbar
Cook Children's Hospital
Career Start Year 2003
Number of shared co-authors 17
Jos?? M Castellano
Hospital Universitario HM Monteprincipe, Grupo HM Hospitales
Career Start Year 2003
Number of shared co-authors 0
Svati H Shah
Duke Molecular Physiology Institute
Career Start Year 2002
Number of shared co-authors 14
Vijay Nambi
Baylor College of Medicine
Career Start Year 2002
Number of shared co-authors 5
Maciej Banach
Medical University of Lodz (MUL)
Career Start Year 2000
Number of shared co-authors 0
Tanja B Grammer
Universitat Heidelberg
Career Start Year 1999
Number of shared co-authors 7
Scott M Damrauer
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 24
Samia Mora
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1999
Number of shared co-authors 3
Michael D Shapiro
Wake Forest University School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Joshua A Beckman
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 0
Salim S Virani
Baylor College of Medicine
Career Start Year 1997
Number of shared co-authors 1
Marc S Sabatine
Brigham and Women's Hospital
Career Start Year 1995
Number of shared co-authors 5
Eric J G Sijbrands
Erasmus MC University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 8
Muredach P Reilly
Vagelos College of Physicians and Surgeons, Columbia University
Career Start Year 1992
Number of shared co-authors 16
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Career Start Year 1991
Number of shared co-authors 13
Karol E Watson
David Geffen School of Medicine, University of California los angeles
Career Start Year 1989
Number of shared co-authors 1
Vincent Mooser
McGill University
Career Start Year 1987
Number of shared co-authors 11
Christie M Ballantyne
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 22
Jane A Leopold
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1986
Number of shared co-authors 0
Christopher J O'Donnell
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 29
Winfried M??rz
Medical Clinic V, University of Heidelberg
Career Start Year 1983
Number of shared co-authors 18
Thomas A Pearson
Departments of Epidemiology and Health Services Research, University of Florida
Career Start Year 1975
Number of shared co-authors 1
Richard E Gregg
Advanced Algorithm Research Center
Career Start Year 1972
Number of shared co-authors 2
Philip Greenland
Feinberg School of Medicine, Northwestern University
Career Start Year 1972
Number of shared co-authors 11
Neil J Stone
Feinberg School of Medicine, Northwestern University
Career Start Year 1971
Number of shared co-authors 0
Emile R Mohler
University of Pennsylvania
Career Start Year 1960
Number of shared co-authors 3

Collaborators

Iftikhar J Kullo
Mayo Clinic
Co-authored papers 16
Xiao Fan
Mayo Clinic
Co-authored papers 5
Merin Jose
Mayo Clinic
Co-authored papers 3
David C Kochan
Mayo Clinic
Co-authored papers 3
Pedro J Caraballo
Mayo Clinic
Co-authored papers 2
QiPing Feng
Vanderbilt University Medical Center
Co-authored papers 2
Wei-Qi Wei
Vanderbilt University Medical Center
Co-authored papers 2
Lars Lind
Co-authored papers 2
Erin M Winkler
Uniformed Services University of the Health Sciences
Co-authored papers 2
Elisabeth A Rosenthal
University of Washington Medical Center
Co-authored papers 2
Naveed Sattar
Co-authored papers 2
Gail P Jarvik
University of Washington Medical Center
Co-authored papers 2
Amy S Shah
Co-authored papers 2
G??ran Bergstr??m
Sahlgrenska University Hospital
Co-authored papers 2
Maryam Kavousi
University Medical Center Rotterdam
Co-authored papers 2
Eric B Larson
University of Washington
Co-authored papers 2
Janet E Olson
Mayo Clinic
Co-authored papers 2
Sathanur R Srinivasan
School of Public Health and Tropical Medicine, Tulane University
Co-authored papers 1
Eric W Klee
Mayo Clinic College of Medicine and Science
Co-authored papers 1
Salim Yusuf
Co-authored papers 1
Joel E Pacyna
Biomedical Ethics Program, Mayo Clinic
Co-authored papers 1
Sheethal Jose
Christian Medical College
Co-authored papers 1
Mullai Murugan
Baylor College of Medicine
Co-authored papers 1
Gabriel Q Shaibi
Arizona State University
Co-authored papers 1
Lisa Bastarache
Vanderbilt University Medical Center
Co-authored papers 1
Catherine Tcheandjieu
Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes
Co-authored papers 1
Erica Smith
Mayo Clinic
Co-authored papers 1
David S Carrell
Kaiser Permanente Washington Health Research Institute
Co-authored papers 1
Joshua C Denny
Vanderbilt University
Co-authored papers 1
Meaghan Carney
Mayo Clinic
Co-authored papers 1
Release 1.2